Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment
- PMID: 26519756
- PMCID: PMC7477794
- DOI: 10.1016/j.canlet.2015.10.022
Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment
Abstract
Myeloid derived suppressor cells (MDSCs) are a group of immature myeloid cells accumulated in most cancer patients and mouse tumor models. MDSCs suppress host immune response and concurrently promote tumor angiogenesis, thereby promote tumor growth and progression. In this review, we discuss recent progresses in expansion and activity of tumor MDSCs, and describe new findings about immunosuppressive function of different subtypes of MDSCs in cancer. We also discussed tumor angiogenic activities and pro-tumor invasion/metastatic roles of MDSCs in tumor progression.
Keywords: M-MDSC; Myeloid-derived suppressor cells; PMN-MDSC; Tumor microenvironment; angiogenesis; immune suppression.
Published by Elsevier Ireland Ltd.
Conflict of interest statement
Conflict of interest
The authors declare no competing financial interests.
Figures
![Fig. 1.](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2c8/7477794/e13260782147/nihms-1624535-f0001.gif)
Similar articles
-
Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.J Cell Physiol. 2018 Apr;233(4):3024-3036. doi: 10.1002/jcp.26075. Epub 2017 Aug 3. J Cell Physiol. 2018. PMID: 28661031 Review.
-
Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.Adv Exp Med Biol. 2020;1224:117-140. doi: 10.1007/978-3-030-35723-8_8. Adv Exp Med Biol. 2020. PMID: 32036608 Review.
-
The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.Front Immunol. 2020 Jul 30;11:1680. doi: 10.3389/fimmu.2020.01680. eCollection 2020. Front Immunol. 2020. PMID: 32849585 Free PMC article. Review.
-
Myeloid-derived suppressor cells and tumor: Current knowledge and future perspectives.J Cell Physiol. 2019 Jul;234(7):9966-9981. doi: 10.1002/jcp.27923. Epub 2018 Dec 7. J Cell Physiol. 2019. PMID: 30537008 Review.
-
Roles of the Exosomes Derived From Myeloid-Derived Suppressor Cells in Tumor Immunity and Cancer Progression.Front Immunol. 2022 Jan 27;13:817942. doi: 10.3389/fimmu.2022.817942. eCollection 2022. Front Immunol. 2022. PMID: 35154134 Free PMC article. Review.
Cited by
-
Functional Regulation of Ginsenosides on Myeloid Immunosuppressive Cells in the Tumor Microenvironment.Integr Cancer Ther. 2019 Jan-Dec;18:1534735419886655. doi: 10.1177/1534735419886655. Integr Cancer Ther. 2019. PMID: 31729239 Free PMC article. Review.
-
Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer.Int J Mol Sci. 2019 Sep 18;20(18):4624. doi: 10.3390/ijms20184624. Int J Mol Sci. 2019. PMID: 31540435 Free PMC article. Review.
-
Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.Front Immunol. 2020 Nov 5;11:598877. doi: 10.3389/fimmu.2020.598877. eCollection 2020. Front Immunol. 2020. PMID: 33250900 Free PMC article. Review.
-
Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review).Int J Oncol. 2024 Sep;65(3):85. doi: 10.3892/ijo.2024.5673. Epub 2024 Jul 26. Int J Oncol. 2024. PMID: 39054950 Free PMC article. Review.
-
M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets.Int J Biol Sci. 2024 Jan 27;20(4):1238-1255. doi: 10.7150/ijbs.90382. eCollection 2024. Int J Biol Sci. 2024. PMID: 38385078 Free PMC article. Review.
References
-
- Dolcetti L, Marigo I, Mantelli B, Peranzoni E, Zanovello P, Bronte V, Myeloid-derived suppressor cell role in tumor-related inflammation, Cancer Lett. 267 (2008) 216–225. - PubMed
-
- Arina A, Bronte V, Myeloid-derived suppressor cell impact on endogenous and adoptively transferred T cells, Curr. Opin. Immunol 33 (2015) 120–125. - PubMed
-
- Di Mitri D, Toso A, Alimonti A, Molecular pathways: targeting tumor-infiltrating myeloid-derived suppressor cells for cancer therapy, Clin. Cancer Res. 21 (2015) 3108–3112. - PubMed
-
- Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW, Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13, Cancer Immunol. Immunother. 60(2011)1419–1430. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources